BioAge Labs (BIOA) Stock Price & Financial Analysis
BioAge Labs Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About BioAge Labs
What is the current stock price for BIOA?
As of the latest trading session, BIOA stock trades at $18.04. The 52-week range is $4.07–$24.00, with a day range of $16.07–$18.09.
What is the P/E ratio for BIOA?
The P/E ratio (Price-to-Earnings) for BIOA is shown in the Key Statistics section. This valuation metric helps compare BioAge Labs, Inc. to industry peers.
Does BIOA pay dividends?
BioAge Labs does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for BIOA?
Based on 1 analyst, the consensus for BIOA is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of BIOA?
BioAge Labs's market capitalization is $648.2M, classifying it as a small-cap company. BioAge Labs operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.